Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Biotech process patent bill

Executive Summary

Biotech process patent bill: House Judiciary/Courts & Intellectual Property Subcommittee reports HR 587 out by voice vote May 16 with no amendments. The bill, which received strong bipartisan support during a March 29 subcommittee hearing, would allow a manufacturer to receive a patent for a biotechnological process if it makes or uses a composition of matter that itself is novel and nonobvious ("The Pink Sheet" April 3, T&G-3). No date has been set for full committee consideration, and there is currently no Senate companion measure...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026272

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel